MODERN CHI MED Sees Stable Share Structure in March 2026, Reaffirms Public Float Compliance

Bulletin Express04-01

Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming that no changes occurred in either its authorised or issued share capital during the month.

• Authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million.

• Issued share capital was unchanged at 720.00 million ordinary shares; the company holds no treasury shares.

• No share options, warrants, convertible securities, or other share-issuance arrangements were outstanding or exercised during the month.

• The company affirmed that it met the Hong Kong Main Board’s minimum 25% public-float requirement as of 31 March 2026.

The filing was submitted on 1 April 2026 and signed by Executive Director Zhang Hongli.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment